As scientists continue to investigate the roots of autism, a generic cancer drug might hold the key.
\nLeucovorin is prescribed to reduce the side effects of chemo. But in several studies conducted over the past 13 years, Dr. Richard Frye has compiled growing evidence that it can improve signs of autism, even leading nonverbal children to speak for the first time.
\nHe told The Post that he believes these successes could be valuable in both treating autism and \u2014 down the line \u2014 potentially preventing the disorder altogether.<\/p>\n
Dr. Richard Frye has been working with autistic children for more than two decades.<\/p>\n
Autism spectrum disorder encompasses a broad range of conditions that affect how people learn, behave, communicate and interact with others.
\nIn recent years, the number of autism diagnoses in the US has skyrocketed, increasing by 175% between 2011 and 2022, largely driven by a spike in cases among young people. According to the CDC, around 1 in 36 children are on the spectrum in the US.
\nResearchers point to \u201cincreased advocacy and education\u201d as one possible reason for the surge, with more people getting themselves or their children screened. Others suggest that the uptick could be attributed to shifts in screening practices, policy changes, environmental factors and evolving diagnosis definitions.<\/p>\n
Frye first turned to leucovorin as a potential treatment in the early 2000s after observing a striking pattern in children with autism.
\n\u201cI started to realize that the neurochemistry in the brain was off,\u201d he said.
\nOverall, research suggests about 30 in every 1,000 US children between the ages of 5 and 8 have an autism diagnosis.
\nAround the same time, new research emerged showing that many children with neurodevelopmental disorders had low levels of folate (vitamin B9) in their brains \u2014 a condition known as cerebral folate deficiency (CFD).
\nNotably, scientists also discovered that many of these children carried folate receptor alpha (FR\u237a) autoantibodies, which block the proper transport of folate into the brain.
\nIn fact, one study found that more than 75% of children with autism had FR\u237a autoantibodies, compared to just 10% to 15% of children without the disorder.
\nIntrigued by these findings, Frye began testing his own patients and found that many of them had FR\u237a autoantibodies.
\nHe started treating some with leucovorin, a generic drug often used to alleviate the side effects of cancer treatments.
\nFrye chose leucovorin because it\u2019s derived from folic acid, a form of folate, which is an essential B vitamin that helps the body repair and create new healthy cells. Research has shown that treating CFD patients with leucovorin can boost their folate levels by bypassing the blockage caused by FR\u237a autoantibodies.
\nLeucovorin is typically reserved for cancer patients, though it can be prescribed off-label for other purposes.
\nMany of his patients saw \u201creally dramatic improvement\u201d soon after starting the drug.<\/p>\n
One of the most remarkable improvements Frye has observed is in nonverbal children with autism who suddenly began speaking.
\nIn a 2012 clinical trial, Frye and his team tested leucovorin on 44 children with both autism and FR\u237a autoantibodies. One-third of those treated with the drug showed significant language improvement.
\n\u201cThe great thing about leucovorin is that it\u2019s a B vitamin, which is water soluble. So the worst thing you could do if you\u2019re given leucovorin is make expensive pee.\u201d
\nIn another study published in 2018, Frye examined 48 children with autism and language impairments. Half were given leucovorin, while the other half received a placebo.
\nAfter 12 weeks, those who took the medication showed \u201cimprovement in measures of verbal communication\u201d compared to the control group, particularly in those with FR\u237a autoantibodies.
\nMason Conner was nonverbal until age 3, when his parents gave him leucovorin.
\nHowever, Frye noted that leucovorin on its own isn\u2019t a cure-all. While his patients were taking the medication, they also continued other therapeutic interventions, such as applied behavior analysis and speech therapy.<\/p>\n
\nSubscribe to our weekly Post Care newsletter!\n<\/p>\n
Frye\u2019s team is now exploring whether leucovorin could help with other characteristics associated with autism, such as difficulty socializing.
\nIn older children treated with the drug, he observed not only an increase in the number of words they could speak, but also improvements in their comprehension and a more sophisticated use of language.
\nStudies suggest leucovorin can boost folate levels in people with Down Syndrome, who often have lower levels.<\/p>\n
Frye said he \u201cdefinitely\u201d believes leucovorin\u2019s success in treating children with autism offers valuable insights into the underlying factors potentially contributing to the disorder.
\n\u201cWe know that in about half of the kids with the folate autoantibody, their mothers have it too,\u201d he said. \u201cWe are thinking that they have a double whammy of no folate before birth and then after they\u2019re born.\u201d
\nBoys are four times as likely to be diagnosed with autism compared to girls, but the gender gap is narrowing.
\nFrye and his colleagues are now studying whether autism-like traits or risk factors can be passed down through generations, even if the ancestor did not have the disorder.
\n\u201cIf we identify it in parents, we\u2019ll be able to treat them and maybe minimize or prevent autism from developing in the first place,\u201d he said.
\n\u201cThat\u2019s one of our major goals.\u201d<\/p>\n
Leucovorin has been used for decades to alleviate the harmful effects of cancer treatments. While doctors can prescribe it off-label for other purposes, Frye noted that many are \u201cvery reluctant\u201d to do so due to unfamiliarity with the drug.
\nFrye is currently testing a new form of leucovorin, hoping it will one day receive FDA approval specifically for treating autism.
\nIn the meantime, he encourages parents to discuss the possibility of leucovorin with their child\u2019s doctor or consult a specialist to explore whether it might be beneficial.
\n\u201cWhat I\u2019ve found is that the ability of the child to recover is correlated with the ability of the parent to advocate for them,\u201d Frye said.<\/p>\n
Leucovorin has shown promising results in treating autism, particularly in children with cerebral folate deficiency. While it is not a cure-all, it can be a valuable tool in conjunction with other therapies. Further research is needed to fully understand the potential of leucovorin in treating autism, but the current evidence suggests that it may be a game-changer for many families.<\/p>\n
Q: What is leucovorin?
\nA: Leucovorin is a generic cancer drug that has been shown to improve signs of autism in some children.
\nQ: How does leucovorin work?
\nA: Leucovorin boosts folate levels in the brain, which can help to alleviate symptoms of autism.
\nQ: Is leucovorin a cure for autism?
\nA: No, leucovorin is not a cure for autism, but it can be a valuable tool in conjunction with other therapies.
\nQ: Can leucovorin be prescribed off-label?
\nA: Yes, doctors can prescribe leucovorin off-label for purposes other than cancer treatment, but they may be reluctant to do so due to unfamiliarity with the drug.
\nQ: What are the potential side effects of leucovorin?
\nA: The side effects of leucovorin are generally mild, and the worst that can happen is that it may cause expensive urine.
\nQ: Can leucovorin be used to treat other conditions?
\nA: Yes, leucovorin may be beneficial for people with Down Syndrome, schizophrenia, certain seizure disorders, and even dementia.<\/p>\n","protected":false},"excerpt":{"rendered":"
Introduction to Autism Treatment As scientists continue to investigate the roots of autism, a generic cancer drug might hold the key. Leucovorin is prescribed to reduce the side effects of chemo. But in several studies conducted over the past 13 years, Dr. Richard Frye has compiled growing evidence that it can improve signs of autism, […]<\/p>\n","protected":false},"author":6,"featured_media":14624,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[22],"tags":[],"class_list":{"0":"post-14623","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-wellness"},"jetpack_featured_media_url":"https:\/\/i1.wp.com\/nypost.com\/wp-content%2Fuploads%2Fsites%2F2%2F2025%2F03%2F100467279-1.jpg?quality%3D90%26strip%3Dall&w=1920&resize=1920,1279&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts\/14623"}],"collection":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/comments?post=14623"}],"version-history":[{"count":1,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts\/14623\/revisions"}],"predecessor-version":[{"id":14625,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts\/14623\/revisions\/14625"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/media\/14624"}],"wp:attachment":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/media?parent=14623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/categories?post=14623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/tags?post=14623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}